Development of a candidate multi-epitope vaccine against Sphingobacterium spiritivorum Reverse vaccinology and immunoinformatics approach

Biochemistry, Genetics and Molecular Biology

• Immunoglobulin M 100%
• B Cell 100%
• Infectious Agent 50%
• Vaccine Peptide 50%
• T Cell 50%
• TLR4 50%
• Outer Membrane 50%
• Immunocompetent Cell 50%
• Humoral Immunity 50%

Immunology and Microbiology

• Epitope 100%
• Outer Membrane 50%
• B Cell 50%
• Immunoglobulin M 50%
• Infectious Agent 25%
• Immunocompetent Cell 25%
• TLR4 25%
• T Cell 25%
• Humoral Immunity 25%
• Immunoglobulin G2 25%
• Immunoglobulin G1 25%
• Vaccine Peptide 25%

Pharmacology, Toxicology and Pharmaceutical Science

• Sphingobacterium 100%
• Chimeric Vaccine 66%
• Vaccine Peptide 33%
• Outer Membrane Protein 33%
• Immunoglobulin G1 33%
• Immunoglobulin G2 33%